YUVIWEL
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

YUVIWEL Trademark

Serial Number: 98615005 • Registration: 7840362

YUVIWEL is a trademark filed by Ascendis Pharma Growth Disorders A/S on June 24, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Ascendis Pharma Growth Disorders A/S (2 trademarks)

Tuborg Boulevard 12
Hellerup 2900 , DK

Entity Type: 99

Trademark Details

Filing Date

June 24, 2024

Registration Date

June 24, 2025

Published for Opposition

May 6, 2025

Goods & Services

Pharmaceutical preparations for the treatment of growth disorders; pharmaceutical preparations for the treatment of endocrine disorders; pharmaceutical preparations for the treatment of bone disorders; pharmaceutical preparations for the treatment of skeletal disorders; pharmaceutical preparations for the treatment of genetic disorders affecting bone and skeletal growth; pharmaceutical preparations for the treatment of osteochondrodysplasia, achondroplasia and hypochondroplasia; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth disorders, endocrine disorders, bone disorders, skeletal disorders, osteochondrodysplasia, achondroplasia and hypochondroplasia

Drug delivery devices sold empty, namely, medical devices for injection, syringes for injection, and infusion and injection devices for administering drugs that control the dosage of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, skeletal disorders, osteochondrodysplasia, achondroplasia and hypochondroplasia; medical devices for dosage and injection of pharmaceutical and medical preparations, namely pen-type syringes, medical auto-injectors, autoinjector syringes, injection needles, and autoinjector cartridges; Syringes for medical purposes and for injections; Syringes for injection for medical use, namely syringes in the form of pens for medical and surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of skeletal disorders, osteochondrodysplasia, achondroplasia and hypochondroplasia, namely displays, monitors, controllers for medical fluid injectors; Medical apparatus, namely, infusion and injection devices for administering drugs; Apparatus and instruments for medical diagnostic purposes, namely, dosage management dispensers for medicines containing pre-embedded or installed software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and at a clinic; Dosage management dispensers for administering medicine to patients containing pre-installed or embedded software for medical information management, for guidance and control of medicines, and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 24, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 24, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 6, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 6, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 30, 2025 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 10, 2025 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 27, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 27, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 27, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 27, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 11, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 11, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 23, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 23, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 23, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 23, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 24, 2024 NWOS
NEW APPLICATION ENTERED
Jun 24, 2024 NWAP